SCHEMBL25996402

SCHEMBL25996402

c1ccc(-c2cc3oc4ccccc4c3c3c2[nH]c2ccccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ CDK5 Q00535 3/20 0.43
▸ CDK5R1 Q15078 2/20 0.43
▸ DYRK1A Q13627 2/20 0.43
▸ GSK3A P49840 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ MAP3K11 Q16584 3/20 0.41
▸ MAP3K9 P80192 2/20 0.41
▸ CHEK1 O14757 3/20 0.41
▸ WEE1 P30291 2/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ GABRP O00591 2/20 0.38
▸ GABRD O14764 2/20 0.38
▸ GABRA1 P14867 2/20 0.38
▸ GABRB1 P18505 2/20 0.38
▸ GABRG2 P18507 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25654892 0.84 PLA2G2A (0.40) HPGDSMN1; SMN2MAPK1HTTCDK5
SCHEMBL24519133 0.83 HPGD (0.45) HPGDSMN1; SMN2MAPK1HTTCDK5
SCHEMBL25681420 0.77 MAP3K11 (0.45) HPGDSMN1; SMN2MAPK1HTTCDK5
SCHEMBL28439028 0.77 CDK4 (0.42) HPGDSMN1; SMN2MAPK1HTTCDK5
SCHEMBL26737104 0.77 MAP3K11 (0.44) HPGDSMN1; SMN2MAPK1HTTCDK5
SCHEMBL21085596 0.76 HPGD (0.46) HPGDSMN1; SMN2MAPK1WEE1MEN1
SCHEMBL21282030 0.75 CDK4 (0.58) CDK5CDK5R1DYRK1AWEE1MEN1
SCHEMBL17451755 0.75 GABRP (0.44) CDK5CDK5R1DYRK1AGSK3AGSK3B
SCHEMBL3951987 0.74 HPGD (0.55) HPGDSMN1; SMN2MAPK1HTTCDK5
SCHEMBL18688077 0.74 CDK5 (0.49) CDK5CDK5R1DYRK1AGSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 HPGD 1840/4885SMN1; SMN2 3623/4885MAPK1 4234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback